Mongoose Bio
Blood & Organ Banks · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd Ste 200, Houston, Tex...Website
www.mongoosebio.comRevenue
<$5 MillionIndustry
About Mongoose Bio
Mongoose Bio is an early-stage clinical company focused on revolutionizing T cell precision therapies for cancer treatment, specifically targeting both common and rare solid tumors. The company utilizes a unique approach of epigenetically reprogramming autologous central memory T cells to create long-lasting and effective TCR-T therapeutics. Founded in 2023 and spun out from MD Anderson Cancer Center, Mongoose Bio aims to minimize toxicity and enhance treatment efficacy through innovative outpatient strategies. With a strong foundation in TCR target identification and epigenetics, Mongoose Bio is positioned to address significant challenges in oncology therapeutics.Explore more
SIC Code 28,283NAICS Code 32,325Show moreMongoose Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Mongoose Bio Tech Stack
A closer look at the technologies used by Mongoose Bio
See more technologies
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mongoose Bio
Sign Up For FreeTo access detailed company insights
Mongoose Bio is an early-stage clinical company focused on revolutionizing T cell precision therapies for cancer treatment, specifically targeting both common and rare solid tumors. The company utilizes a unique approach of epigenetically reprogramming autologous central memory T cells to create long-lasting and effective TCR-T therapeutics. Founde... Read More
